← Leaderboards
Nicola Brunetti-Pierri
Baylor College Of Medicine
$464,863
Attributed
$464,863
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $260.1K · FY2007–11$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$464,863 · 6
By mechanism
R00$249,000 · 1
K99$180,000 · 1
P51$35,863 · 4
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Philip Ng$7,705,481
- Brendan Hl Lee$62,781,623
- Michael A Barry$17,628,136
- Masataka Suzuki$902,239
- Lawrence Chan$23,286,228
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyClinically RelevantVectorSafetyNonhuman PrimateEnzyme Replacement TherapyChildMediatingAnimal ModelFaceDeteriorationDisadvantagedFundingPre-ClinicalContractureInvestigationMucopolysaccharidosesCardiopulmonaryGrantDeformityBone Marrow TransplantationJointsDependovirusHepatosplenomegaly
Grant awards (7)
ADENO ASSOCIATED VIRUS (AAV) GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE II$8,649
P51 · FY2011 · RR · contact PI
ADENO ASSOCIATED VIRUS (AAV) GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE II$15,990
P51 · FY2010 · RR · contact PI
HDAd-mediated gene therapy for hemophilia B$249,000
R00 · FY2009 · HL · contact PI
ADENO ASSOCIATED VIRUS (AAV) GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE II$11,097
P51 · FY2009 · RR · contact PI
HDAd-mediated gene therapy for hemophilia B$90,000
K99 · FY2008 · HL · contact PI
ADENO ASSOCIATED VIRUS (AAV) GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE II$127
P51 · FY2008 · RR · contact PI
HDAd-mediated gene therapy for hemophilia B$90,000
K99 · FY2007 · HL · contact PI